Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 7575639)

Published in Biochem Pharmacol on September 07, 1995

Authors

F Viola1, P Brusa, G Balliano, M Ceruti, O Boutaud, F Schuber, L Cattel

Author Affiliations

1: Istituto di Chimica Farmaceutica Applicata, Università di Torino, Italy.

Articles by these authors

Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. Proc Natl Acad Sci U S A (1995) 1.91

Alpha-methyl ornithine, a potent competitive inhibitor of ornithine decarboxylase, blocks proliferation of rat hepatoma cells in culture. Proc Natl Acad Sci U S A (1976) 1.76

Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release (2000) 1.73

Systematic analysis of yeast strains with possible defects in lipid metabolism. Yeast (1999) 1.52

Identification of a naturally occurring peroxidase-lipoxygenase fusion protein. Science (1997) 1.52

Mice deficient for the ecto-nicotinamide adenine dinucleotide glycohydrolase CD38 exhibit altered humoral immune responses. Blood (1998) 1.50

Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci (2000) 1.42

Efficient epoxidation of unsaturated fatty acids by a hydroperoxide-dependent oxygenase. J Biol Chem (1990) 1.28

Unifying mechanism for Aplysia ADP-ribosyl cyclase and CD38/NAD(+) glycohydrolases. Biochem J (2000) 1.25

Human CD38 is an authentic NAD(P)+ glycohydrolase. Biochem J (1998) 1.22

Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal-cell carcinomas. Int J Cancer (1989) 1.19

Mechanism of reaction of fatty acid hydroperoxides with soybean peroxygenase. J Biol Chem (1993) 1.17

Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol (2001) 1.16

CD38: a new paradigm in lymphocyte activation and signal transduction. Immunol Rev (1998) 1.09

Differential reactivity of maleimide and bromoacetyl functions with thiols: application to the preparation of liposomal diepitope constructs. Bioconjug Chem (2000) 1.09

Biphasic induction of ornithine decarboxylase and putrescine levels in growing HTC cells. Biochem Biophys Res Commun (1975) 1.08

NAD+ glycohydrolase, an ecto-enzyme of calf spleen cells. Biochem J (1983) 1.08

On the chemical reactivity of aminoacyl-tRNA ester bond. I. Influence of pH and nature of the acyl group on the rate of hydrolysis. Biochimie (1974) 1.07

Mechanism of cyclization of pyridine nucleotides by bovine spleen NAD+ glycohydrolase. J Biol Chem (1996) 1.00

CD38 signaling in B lymphocytes is controlled by its ectodomain but occurs independently of enzymatically generated ADP-ribose or cyclic ADP-ribose. J Immunol (1999) 0.97

Characterization of the coral allene oxide synthase active site with UV-visible absorption, magnetic circular dichroism, and electron paramagnetic resonance spectroscopy: evidence for tyrosinate ligation to the ferric enzyme heme iron. Biochemistry (2001) 0.97

Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization. Langmuir (2006) 0.95

Slow-binding inhibition of NAD+ glycohydrolase by arabino analogues of beta-NAD. J Biol Chem (1992) 0.94

12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity. Thromb Haemost (2013) 0.94

Occurrence of fatty acid epoxide hydrolases in soybean (Glycine max). Purification and characterization of the soluble form. Biochem J (1992) 0.93

In yeast sterol biosynthesis the 3-keto reductase protein (Erg27p) is required for oxidosqualene cyclase (Erg7p) activity. Biochim Biophys Acta (2003) 0.91

New coupling reagents for the preparation of disulfide cross-linked conjugates with increased stability. Bioconjug Chem (1997) 0.91

Calf-spleen nicotinamide--adenine dinucleotide glycohydrolase. Solubilization purification and properties of the enzyme. Eur J Biochem (1976) 0.90

Efficient gene delivery with neutral complexes of lipospermine and thiol-reactive phospholipids. Biochem Biophys Res Commun (1995) 0.90

From conventional to stealth liposomes: a new Frontier in cancer chemotherapy. J Chemother (2004) 0.90

Regio- and enantioselectivity of soybean fatty acid epoxide hydrolase. J Biol Chem (1992) 0.89

Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs. J Pharm Sci (1997) 0.89

Formation of highly reactive gamma-ketoaldehydes (neuroketals) as products of the neuroprostane pathway. J Biol Chem (2001) 0.89

Mechanistic implications of cyclic ADP-ribose hydrolysis and methanolysis catalyzed by calf spleen NAD+glycohydrolase. Biochem Biophys Res Commun (1994) 0.89

Studies on polyamine biosynthesis in Euglena gracilis. Biochim Biophys Acta (1979) 0.89

Inhibition of S-adenosyl-L-methionine sterol-C-24-methyltransferase by analogues of a carbocationic ion high-energy intermediate. Structure activity relationships for C-25 heteroatoms (N, As, S) substituted triterpenoid derivatives. J Biol Chem (1984) 0.88

Molecular cloning and functional expression of bovine spleen ecto-NAD+ glycohydrolase: structural identity with human CD38. Biochem J (2000) 0.88

The stereochemistry of calf spleen NAD-glycohydrolase-catalyzed NAD methanolysis. FEBS Lett (1976) 0.88

Inhibition of sterol biosynthesis in Saccharomyces cerevisiae by N,N-diethylazasqualene and derivatives. Biochim Biophys Acta (1988) 0.88

The squalene-2,3-epoxide cyclase as a model for the development of new drugs. Lipids (1986) 0.87

Calf spleen NAD+ glycohydrolase: solubilization, purification, and properties of the intact form of the enzyme. Arch Biochem Biophys (1993) 0.87

In vitro inhibition of animal and higher plants 2,3-oxidosqualene-sterol cyclases by 2-aza-2,3-dihydrosqualene and derivatives, and by other ammonium-containing molecules. Biochem Pharmacol (1985) 0.87

Clinical and pharmacokinetic data of a docetaxel-epirubicin combination in metastatic breast cancer. Breast Cancer Res Treat (2001) 0.86

CD38 in T- and B-cell functions. Chem Immunol (2000) 0.86

Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A. Mol Immunol (1993) 0.86

Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel. J Control Release (2000) 0.86

Drug design based on biosynthetic studies: synthesis, biological activity, and kinetics of new inhibitors of 2,3-oxidosqualene cyclase and squalene epoxidase. Steroids (1989) 0.86

Immunogenicity of new heterobifunctional cross-linking reagents used in the conjugation of synthetic peptides to liposomes. J Immunol Methods (1996) 0.86

Stereochemistry of the epoxidation of fatty acids catalyzed by soybean peroxygenase. Biochem Biophys Res Commun (1990) 0.85

Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma. Ann Oncol (2005) 0.85

Preferential cyclization of 2,3(S):22(S),23-dioxidosqualene by mammalian 2,3-oxidosqualene-lanosterol cyclase. Biochem Biophys Res Commun (1992) 0.85

Access of the substrate to the active site of squalene and oxidosqualene cyclases: comparative inhibition, site-directed mutagenesis and homology-modelling studies. Biochem Soc Trans (2005) 0.85

Reaction of tris-(hydroxymethyl)-aminomethane with valyl-TYMV-RNA. Biochimie (1971) 0.85

Synthetic lipopeptides incorporated in liposomes: in vitro stimulation of the proliferation of murine splenocytes and in vivo induction of an immune response against a peptide antigen. Mol Immunol (1997) 0.84

Depression after lung transplantation: causes and treatment. Lung (2007) 0.84

Inhibitors of 2,3-oxidosqualene cyclase as tools for studying the mechanism and function of the enzyme. Crit Rev Biochem Mol Biol (1998) 0.84

Differential inhibition of fungal oxidosqualene cyclase by 6E and 6Z isomers of 2,3-epoxy-10-aza-10,11-dihydrosqualene. FEBS Lett (1993) 0.84

2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase. J Med Chem (1992) 0.83

Subcellular localization of oxidosqualene cyclases from Arabidopsis thaliana, Trypanosoma cruzi, and Pneumocystis carinii expressed in yeast. Lipids (2002) 0.83

Stereocontrolled hydrolysis of the linoleic acid monoepoxide regioisomers catalyzed by soybean epoxide hydrolase. Eur J Biochem (1995) 0.83

Poly(ethylene glycol)-human serum albumin-paclitaxel conjugates: preparation, characterization and pharmacokinetics. J Control Release (2001) 0.83

Studies on the association of NAD glycohydrolase with membranes in calf spleen. Eur J Biochem (1980) 0.83

Antitumoral properties and reduced toxicity of LPS targeted to macrophages via normal or mannosylated liposomes. Anticancer Res (1990) 0.83

Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by 4',6-diamidino-2-phenylindole, 6-amidinoindole and benzamidine: a comparative thermodynamic and X-ray structural study. Biophys Chem (1995) 0.83

Preparation of neo-galactosylated liposomes and their interaction with mouse peritoneal macrophages. Biochim Biophys Acta (1988) 0.82

Preparation of analogues of NAD+ as substrates for a sensitive fluorimetric assay of nucleotide pyrophosphatase. Biochem J (1984) 0.82

Polyamines. Biological modulators of membrane fusion. Biochim Biophys Acta (1983) 0.82

Comparison of blocked and non-blocked ricin-antibody immunotoxins against human gastric carcinoma and colorectal adenocarcinoma cell lines. Cancer Immunol Immunother (1988) 0.82

Prevention, education and information: the role of the community pharmacist in the management of headaches. Neurol Sci (2014) 0.81

Characterization and partial purification of squalene-2,3-oxide cyclase from Saccharomyces cerevisiae. Arch Biochem Biophys (1992) 0.81

Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling. Biochem J (2001) 0.81

Calf-spleen nicotinamide-adenine dinucleotide glycohydrolase. Properties of the active site. Eur J Biochem (1978) 0.81

Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study. J Mol Biol (1996) 0.81

Occurrence of bovine spleen CD38/NAD+glycohydrolase disulfide-linked dimers. Biochem Mol Biol Int (1998) 0.81

Genetic analyses involving interactions between the ergosterol biosynthetic enzymes, lanosterol synthase (Erg7p) and 3-ketoreductase (Erg27p), in the yeast Saccharomyces cerevisiae. Biochim Biophys Acta (2008) 0.81

Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases. Lipids (2001) 0.81

FEV6 assessment in spirometric abnormalities screening: the first population-based study in Italian pharmacies. Panminerva Med (2013) 0.81

Calf spleen NAD glycohydrolase. Comparison of the catalytic properties of the membrane-bound and the hydrosoluble forms of the enzyme. Eur J Biochem (1979) 0.80

Inhibition of cholesterol biosynthesis in 3T3 fibroblasts by 2-aza-2,3-dihydrosqualene, a rationally designed 2,3-oxidosqualene cyclase inhibitor. Biochem Pharmacol (1986) 0.80